Clinical Trial Update: American Ginseng in Treating Patients With Fatigue Caused by Cancer [Phase 3]

View source ↗

Summary

A phase 3 trial evaluating American ginseng for cancer-related fatigue has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Lymphoproliferative Disorder
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Disorders
• Precancerous Condition

Drugs mentioned

• American Ginseng (Panax quinquefolius)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Chronic Myeloproliferative Disorders, Fatigue | Phase 3 | Status: COMPLETED | Results posted: 2014-08-06